Recordati Industria Chimica e Farmaceutica Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Rob Koremans
Chief executive officer
€2.5m
Total compensation
| CEO salary percentage | 23.6% |
| CEO tenure | 2.9yrs |
| CEO ownership | n/a |
| Management average tenure | 4.2yrs |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | €423m |
| Jun 30 2024 | n/a | n/a | €387m |
| Mar 31 2024 | n/a | n/a | €389m |
| Dec 31 2023 | €2m | €590k | €389m |
| Sep 30 2023 | n/a | n/a | €375m |
| Jun 30 2023 | n/a | n/a | €389m |
| Mar 31 2023 | n/a | n/a | €340m |
| Dec 31 2022 | €2m | €590k | €312m |
| Sep 30 2022 | n/a | n/a | €331m |
| Jun 30 2022 | n/a | n/a | €330m |
| Mar 31 2022 | n/a | n/a | €393m |
| Dec 31 2021 | €154k | n/a | €386m |
Compensation vs Market: Rob's total compensation ($USD2.62M) is below average for companies of similar size in the US market ($USD12.66M).
Compensation vs Earnings: Rob's compensation has been consistent with company performance over the past year.
CEO
Rob Koremans (62 yo)
2.9yrs
Tenure
€2,498,000
Compensation
Dr. Robert Koremans, also known as Rob, M.D. serves as Chief Executive Officer and Director of Recordati Industria Chimica e Farmaceutica S.p.A. since December 1, 2021. Dr. Koremans served as Chief Executi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.9yrs | €2.50m | no data | |
| Group CFO & Executive Director | 5yrs | €1.23m | no data | |
| Executive Director | no data | no data | no data | |
| Executive Director | 5.8yrs | no data | no data | |
| Executive Director | 4.6yrs | no data | no data | |
| VP & Head of Investor Relations | less than a year | no data | no data | |
| Group Chief Legal Officer | 1.6yrs | no data | no data | |
| Group Communications Director | no data | no data | no data | |
| Executive VP of Corporate Development | 8.2yrs | no data | no data | |
| Group Chief People & Culture Officer | less than a year | no data | no data | |
| Chief Medical Officer | 5.8yrs | no data | no data | |
| Executive Vice President of Specialty & Primary Care Business Unit | 3.8yrs | no data | no data |
4.2yrs
Average Tenure
55yo
Average Age
Experienced Management: RICF.Y's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.9yrs | €2.50m | no data | |
| Group CFO & Executive Director | 2.8yrs | €1.23m | no data | |
| Executive Director | 5.9yrs | no data | no data | |
| Executive Director | 5.9yrs | no data | no data | |
| Executive Director | 4.6yrs | no data | no data | |
| Non-Executive Chairman | 26.6yrs | €315.00k | no data | |
| Independent Non-Executive Director | 4.6yrs | €80.00k | no data | |
| Lead Independent Director | 10.6yrs | €103.00k | no data | |
| Independent Director | 2.8yrs | €90.00k | no data | |
| Chairman of Statutory Auditor Board | 7.6yrs | no data | no data | |
| Independent Non-Executive Director | 5.8yrs | €85.00k | no data | |
| Non-Executive Vice Chairman | 4.6yrs | €90.00k | no data |
5.2yrs
Average Tenure
54.5yo
Average Age
Experienced Board: RICF.Y's board of directors are considered experienced (5.2 years average tenure).